Cerebral Amyloid Angiopathy Clinical Trial
Official title:
SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA): Italian Network for the Study of CAA
Cerebral amyloid angiopathy (CAA) is one of the major types of cerebral small vessel disease,
and a leading cause of spontaneous intracerebral hemorrhage and cognitive decline in elderly
patients. Although increasingly detected, a number of aspects including the pathophysiology,
the clinical and neuroradiological phenotype and the disease course are still under
investigation. The incomplete knowledge of the disease limits the implementation of evidence
based guidelines on patient's clinical management and the development of treatments able to
prevent or reduce disease progression.
The SENECA (SEarchiNg biomarkErs of Cerebral Angiopathy) project is the first Italian
multicentre cohort study aimed at better defining the disease natural history and identifying
clinical and neuroradiological markers of disease progression. By a multidisciplinary
approach and the collection of a large and well phenotyped series and biorepository of CAA
patients, the study is ultimately expected to improve the diagnosis and the knowledge of CAA
pathophysiological mechanisms.
The SENECA is an Italian multicenter network integrating the experience of neurologists, neuroradiologists, neuro-ophthalmologists and biologists and allowing the standardized collection of a well-characterized wide series of sporadic and familial CAA patients. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05486897 -
Periventricular White Matter Hyperintensities in Cerebral Amyloid Angiopathy and Hypertensive Arteriopathy
|
||
Recruiting |
NCT03969732 -
Multimodal Biomarkers for Diagnosis and Prognosis in CAA
|
Phase 3 | |
Completed |
NCT03542656 -
Application of Amyloid PET in Cerebral Amyloid Angiopathy
|
Phase 3 | |
Recruiting |
NCT04604587 -
MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA
|
Phase 3 | |
Completed |
NCT05565144 -
Brain Hemorrhage and Functional Outcome in Stroke Patients With CAA Features on Pre-thrombolysis MRI Treated With Intravenous Thrombolysis (Thrombolysis in CAA) ( Thromb in CAA )
|
||
Active, not recruiting |
NCT03464344 -
Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.
|
N/A | |
Completed |
NCT03824197 -
Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)
|
N/A | |
Recruiting |
NCT06393712 -
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
|
Phase 2 | |
Active, not recruiting |
NCT01856699 -
Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy
|
N/A | |
Recruiting |
NCT06128824 -
High Frequency Imaging in Cerebral Amyloid Angiopathy
|
||
Completed |
NCT01821118 -
Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy
|
Phase 2 | |
Not yet recruiting |
NCT06421532 -
Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy
|
Phase 2 | |
Completed |
NCT05394636 -
Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy
|
||
Recruiting |
NCT05207475 -
Safety and Efficacy of Remote Ischemic Conditioning on Cerebral Amyloid Angiopathy. (RIC-CAA)
|
N/A | |
Recruiting |
NCT04757597 -
Remote Ischemic Conditioning for Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage
|
N/A | |
Not yet recruiting |
NCT02361411 -
Methods of Etiological Diagnosis of Cerebral Amyloid Angiopathy
|
N/A | |
Not yet recruiting |
NCT04654026 -
the Safety and Efficacy of Antiplatelet Therapy in Patients of CAA
|
||
Completed |
NCT05082194 -
Balance Eyesight and Muscle Tension in the Cervical Spine in Cerebral Amyloid Angiopathy
|
||
Completed |
NCT04825808 -
Detailed Clinical and MRI Characteristics in Primary Non-traumatic Convexity Subarachnoid Haemorrhage Elderly Patients.
|
||
Recruiting |
NCT05680389 -
Antibiotics Against Amyloid Angiopathy
|
Phase 1/Phase 2 |